Can biomarkers help us hit targets in difficult-to-treat asthma?-Reference-Cited by-同舟云学术

Can biomarkers help us hit targets in difficult-to-treat asthma?

Published:2017-03-01 Issue:3 Volume:22 Page:430-442
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Fricker Michael¹,Heaney Liam G.²,Upham John W.³⁴

Affiliation:

1. Centre of Excellence in Severe Asthma, School of Medicine and Public Health, Hunter Medical Research Institute; University of Newcastle; Newcastle New South Wales Australia

2. Centre for Experimental Medicine, Wellcome-Wolfson Institute for Experimental Medicine; Queens University Belfast; Belfast UK

3. Translational Research Institute; The University of Queensland; Brisbane Queensland Australia

4. Department of Respiratory and Sleep Medicine; Princess Alexandra Hospital; Brisbane Queensland Australia

Funder

NHMRC Center of Excellence for Severe Asthma

UK Medical Research Council

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13014/fullpdf

Reference112 articles.

1. 2016 http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/

2. Bel EH Sousa A Fleming L Bush A Chung KF Versnel J Wagener AH Wagers SS Sterk PJ Compton CH Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (U-BIOPRED) Consortium Consensus Generation Thorax 2011 66:

3. Severe asthma treatment: need for characterising patients;Heaney;Lancet,2005

4. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014

5. The prevalence of nonadherence in difficult asthma;Gamble;Am. J. Respir. Crit. Care Med.,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma;Allergy;2024-08-08

2. Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

3. Mild asthma: Lessons learned and remaining questions;Respiratory Medicine;2023-09

4. Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study;Biomedicines;2022-10-18

5. Phenotyping, Precision Medicine, and Asthma;Seminars in Respiratory and Critical Care Medicine;2022-10